Retrospective analysis comparing insulin degludec and insulin glargine in patients with type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Primary endpoint has not been met. (Dose of long-acting insulin required to achieve target fasting plasma glucose)